In addition, GW6471 treatment further increased the inhibitory effect of sorafenib on the in vitro motility and invasion of HCC cells with Linc01056 knockdown (Fig. S6f & S6g). The gene discussed is LINC01056; the disease is hepatocellular carcinoma.